CancerIQ Raises $14M Series B Funding to Improve Access to Innovations in Cancer Early Detection and Prevention

Merck Global Health Innovation Fund and Amgen Ventures lead round, which closed on the heels of a new national report calling for more equity in cancer screening

Link Here: https://www.businesswire.com/news/home/20220303005142/en/CancerIQ-Raises-14M-Series-B-Funding-to-Improve-Access-to-Innovations-in-Cancer-Early-Detection-and-Prevention

Previous
Previous

Moving Analytics Gains Approval from Centers for Medicare and Medicaid Services

Next
Next

Medable and CVS Health partner to boost access to clinical trials